Efficacy of Fosfomycin-Containing Regimens for Treatment of Bacteremia Due to Pan-Drug Resistant Acinetobacter baumannii in Critically Ill Patients: A Case Series Study

In search for a synergistic combination against pandrug-resistant A. baumannii; methodological considerations

(2022) Stamatis Karakonstantis et al.   INFECTION

Clinical Impact of COVID-19 on Multi-Drug-Resistant Gram-Negative Bacilli Bloodstream Infections in an Intensive Care Unit Setting: Two Pandemics Compared

(2022) Francesco Cogliati Dezza et al.   Antibiotics-Basel

The Burden of Carbapenem-Resistant Acinetobacter baumannii in ICU COVID-19 Patients: A Regional Experience

(2022) Giorgia Montrucchio et al.   Journal of Clinical Medicine

Efficacy and safety of intravenous fosfomycin for the treatment of carbapenem-resistant Klebsiella pneumoniae

(2022) Pınar Aysert-Yildiz et al.   JOURNAL OF CHEMOTHERAPY

Therapeutic Drug Monitoring of Tigecycline in 67 Infected Patients and a Population Pharmacokinetics/Microbiological Evaluation of A. baumannii Study

(2021) Tianli Yang et al.   Frontiers in Microbiology

Systematic Review of Antimicrobial Combination Options for Pandrug-Resistant Acinetobacter baumannii

(2021) Stamatis Karakonstantis et al.   Antibiotics-Basel

COVID-19 and Antimicrobial Resistance: Data from the Greek Electronic System for the Surveillance of Antimicrobial Resistance—WHONET-Greece (January 2018–March 2021)

(2021) Michalis Polemis et al.   Life-Basel

Fosfomycin as Partner Drug for Systemic Infection Management. A Systematic Review of Its Synergistic Properties from In Vitro and In Vivo Studies

(2020) Roberta Maria Antonello et al.   Antibiotics-Basel

Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach based on the mechanisms of resistance to carbapenems

(2020) Stamatis Karakonstantis et al.   INFECTION

Excess mortality due to pandrug-resistant Acinetobacter baumannii infections in hospitalized patients

(2020) S. Karakonstantis et al.   JOURNAL OF HOSPITAL INFECTION

Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study

(2020) Alessandro Russo et al.   Infectious Diseases and Therapy

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections

(2019) Yohei Doi   CLINICAL INFECTIOUS DISEASES

High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial

(2017) J Nowak et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Risk Factors, Clinical Presentation, and Outcome of Acinetobacter baumannii Bacteremia

(2017) Tala Ballouz et al.   Frontiers in Cellular and Infection Microbiology

Fosfomycin

(2016) Matthew E. Falagas et al.   CLINICAL MICROBIOLOGY REVIEWS

The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

(2016) Mervyn Singer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Excess Mortality Associated With Colistin-Tigecycline Compared With Colistin-Carbapenem Combination Therapy for Extensively Drug-Resistant Acinetobacter baumannii Bacteremia

(2015) Aristine Cheng et al.   CRITICAL CARE MEDICINE

Preliminary Study of Colistin versus Colistin plus Fosfomycin for Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections

(2014) Rujipas Sirijatuphat et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumanniiin a critical setting: a matched cohort analysis

(2014) Yu-Chung Chuang et al.   BMC INFECTIOUS DISEASES

Combination antibiotic treatment versus monotherapy for multidrug-resistant, extensively drug-resistant, and pandrug-resistant Acinetobacter infections: a systematic review

(2014) P. Poulikakos et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies

(2009) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

In vitro synergistic activity of tigecycline and colistin against XDR-Acinetobacter baumannii

(2009) Murat Dizbay et al.   JOURNAL OF ANTIBIOTICS